Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Sorbic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 6/20 | 0.33 |
| ▸ | CNR1 | P21554 | 4/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorbic Acid SCHEMBL3640 | 1.00 | — | — | |
| Sorbic Acid SCHEMBL3641 | 1.00 | — | — | |
| Sorbic Acid SCHEMBL29573362 | 1.00 | CA4 (0.40) | CA4CA1CA9BBOX1ALDH1A1 | |
| Sorbic Acid SCHEMBL929156 | 1.00 | CA4 (0.40) | CA4CA1CA9BBOX1ALDH1A1 | |
| Sorbic Acid SCHEMBL30195487 | 0.97 | CA4 (0.43) | CA4CA1CA9BBOX1ALDH1A1 | |
| Sorbic Acid SCHEMBL7567295 | 0.97 | CA4 (0.38) | CA4CA1CA9BBOX1ALDH1A1 | |
| Potassium Ion SCHEMBL2563944 | 0.97 | ALDH1A1 (0.39) | CA4CA1CA9BBOX1ALDH1A1 | |
| Sorbic Acid SCHEMBL5328357 | 0.97 | CA4 (0.43) | CA4CA1CA9BBOX1ALDH1A1 | |
| Sorbic Acid SCHEMBL29931009 | 0.97 | CA4 (0.38) | CA4CA1CA9BBOX1ALDH1A1 | |
| Sorbic Acid SCHEMBL7567299 | 0.97 | CA4 (0.38) | CA4CA1CA9BBOX1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0514451-A1 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS. | UNIV TEXAS (US) | 1992-11-25 | — | — | EP | claimed |
| WO-1991011117-A2 | DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-08-08 | — | — | WO | claimed |
| EP-4743050-A1 | 3-HYDROXYPROPYLESTERS AS FOAM AND VISCOSITY MODULATING AGENTS IN SURFACTANT CONTAINING FORMULATIONS | Symrise AG (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025031562-A1 | MYCOSPORINE-LIKE AMINO ACID ANALOGUE COMPOUNDS AND USE THEREOF | SYMRISE AG (DE) | 2025-02-13 | — | — | WO | disclosed |
| WO-2025011747-A1 | 3-HYDROXYPROPYLESTERS AS FOAM AND VISCOSITY MODULATING AGENTS IN SURFACTANT CONTAINING FORMULATIONS | SYMRISE AG (DE) | 2025-01-16 | — | — | WO | disclosed |
| US-20240335364-A1 | COMPOSITIONS OF DICAFFEOYLQUINIC ACIDS WITH TOCOPHEROL | SYMRISE AG (DE) | 2024-10-10 | — | — | US | disclosed |
| US-20240197605-A1 | Composition for Treating Hair, Scalp and Skin | DR. KURT WOLFF GMBH & CO. KG (DE) | 2024-06-20 | — | — | US | disclosed |
| US-20240130942-A1 | Composition for Treating Hair and Skin | DR. KURT WOLFF GMBH & CO. KG (DE) | 2024-04-25 | — | — | US | disclosed |
| US-20240115531-A1 | Composition for Treating Hair and Scalp | DR. KURT WOLFF GMBH & CO. KG (DE) | 2024-04-11 | — | — | US | disclosed |
| EP-4221677-A1 | COMPOSITION FOR TREATING HAIR AND SCALP | Dr. Kurt Wolff GmbH & Co. KG (DE) | 2023-08-09 | — | — | EP | disclosed |
| EP-4221676-A1 | COMPOSITION FOR TREATING HAIR AND SKIN | Dr. Kurt Wolff GmbH & Co. KG (DE) | 2023-08-09 | — | — | EP | disclosed |
| WO-2007068998-A1 | NEW POLYPEPTIDES AND THEIR USE | SEDERMA (FR) | 2007-06-21 | — | — | WO | disclosed |
| EP-1776161-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | Sederma S.A.S. (FR) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006075311-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN EUGLENA EXTRACT | SEDERMA (FR) | 2006-07-20 | — | — | WO | disclosed |
| WO-2005102266-A1 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE UDP GLUCURONOSYL TRANSFERASE (UGT) ENZYMES INDUCER | SEDERMA, SAS (FR) | 2005-11-03 | — | — | WO | disclosed |
| EP-1063895-A1 | STABLE SUSPENSION OF A PARTICULATE COMPONENT | DANISCO A/S (DK) | 2001-01-03 | — | — | EP | disclosed |
| EP-0933990-A4 | INSECTICIDAL COMPOSITION | R & C PRODUCTS PTY LTD (AU) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999048377-A1 | STABLE SUSPENSION OF A PARTICULATE COMPONENT | DANISCO A/S (DK) | 1999-09-30 | — | — | WO | disclosed |
| EP-0933990-A1 | INSECTICIDAL COMPOSITION | R & C PRODUCTS PTY. LIMITED (AU) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998009515-A1 | INSECTICIDAL COMPOSITION | R & C PRODUCTS PTY. LIMITED (AU) | 1998-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240130942-A1 | Composition for Treating Hair and Skin | DPM1, DSG1, SRM | CA4 711/4885CA1 2715/4885CA9 488/4885 |
| US-20240197605-A1 | Composition for Treating Hair, Scalp and Skin | MPG, DPM1, BHMT2 | CA4 140/4885CA1 500/4885CA9 190/4885 |
| US-20240115531-A1 | Composition for Treating Hair and Scalp | DPM1, MGMT, BHMT2 | CA4 294/4885CA1 820/4885CA9 287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.